Ticking Time Bombs: 3 Biotech Stocks to Dump Before the Damage Is Done
Biotech companies can offer some of the most explosive returns for an investor. Small-cap biotech companies are known to shoot up 100% overnight and also to dump 50% in an instant as well. Why is this the case? Well, these companies are highly innovative but have an extremely risky business model. They are highly dependent on receiving successful clinical results and Food and Drug Administration (FDA) approval for their products. Of course, these are no guarantee. With the S&P 500 up over 18% in the past year, it seems that the market is back in a bull run. While it certainly might be, investors should be extra cautious when buying biotech companies because of their great risk. Many of these companies are on the brink of potential collapse. In this article, we will highlight three biotech companies to stay away from that are just not worth your money in a booming market.
https://investorplace.com/2023/09/ticking-time-bombs-3-biotech-stocks-to-dump-before-the-damage-is-done/